Phase 0/I/II Cancer Prevention Clinical Trials Program Clinical Trials

Title Intervention NCT ID Sponsorsort descending Status
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast Afimoxifene, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration NCT03063619 M.D. Anderson Cancer Center Recruiting
Defined Green Tea Catechin Extract in Preventing Liver Cancer in Patients With Cirrhosis Defined Green Tea Catechin Extract, Laboratory Biomarker Analysis, Pharmacological Study, Questionnaire Administration NCT03278925 National Cancer Institute (NCI) Recruiting
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma Aspirin, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration NCT02965703 National Cancer Institute (NCI) Recruiting
Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial... Pharmacokinetic Study, Exemestane, Laboratory Biomarker Analysis, Questionnaire Administration NCT03300557 National Cancer Institute (NCI) Recruiting
Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis Laboratory Biomarker Analysis, Placebo, Quality-of-Life Assessment, Questionnaire Administration, Simvastatin NCT02743364 National Cancer Institute (NCI) Active, not recruiting
MUC1 Vaccine in Preventing Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer MUC1 Peptide-Poly-ICLC Vaccine, Laboratory Biomarker Analysis NCT03300817 National Cancer Institute (NCI) Recruiting
Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial... Imiquimod, Laboratory Biomarker Analysis, Topical Fluorouracil NCT03196180 National Cancer Institute (NCI) Not yet recruiting
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful... Aspirin, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration NCT02521285 National Cancer Institute (NCI) Active, not recruiting
Dolcanatide in Preventing Colorectal Cancer in Healthy Volunteers Laboratory Biomarker Analysis, Placebo, Questionnaire Administration, Dolcanatide NCT03300570 National Cancer Institute (NCI) Active, not recruiting
Iloprost in Preventing Lung Cancer in Former Smokers Iloprost, Placebo, Quality-of-Life Assessment, Questionnaire Administration NCT02237183 National Cancer Institute (NCI) Recruiting

Pages